Synairgen plc (LON:SNG – Get Free Report) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 5.20 ($0.07) and traded as low as GBX 3.60 ($0.05). Synairgen shares last traded at GBX 3.67 ($0.05), with a volume of 113,047 shares.
Synairgen Price Performance
The firm has a market capitalization of £7.54 million, a PE ratio of -91.83 and a beta of -2.23. The company has a 50-day moving average price of GBX 4.02 and a 200-day moving average price of GBX 5.20. The company has a debt-to-equity ratio of 0.09, a current ratio of 6.77 and a quick ratio of 6.35.
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Featured Stories
- Five stocks we like better than Synairgen
- Top Biotech Stocks: Exploring Innovation Opportunities
- How Much Can You Make in Stocks in One Month?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- This Is the Top Large-Cap Stock Insiders Are Buying
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
